Global TB Cases Hit Record High, TB Becomes Top Infectious Disease Killer
By Physician’s Briefing Staff HealthDay Reporter
WEDNESDAY, Oct. 30, 2024 -- The World Health Organization reports that tuberculosis (TB) cases hit a record high in 2023, with more than 8 million diagnoses and 1.25 million deaths, meaning it is once again the leading cause of death from infectious disease after COVID-19 displaced it briefly during the pandemic.
"The fact that TB still kills and sickens so many people is an outrage, when we have the tools to prevent it, detect it, and treat it," WHO Director-General Tedros Adhanom Ghebreyesus, M.D., said in an agency news release. "WHO urges all countries to make good on the concrete commitments they have made to expand the use of those tools, and to end TB."
Some countries are hit harder by the disease than others: It continues to mostly affect people in Southeast Asia, Africa and the Western Pacific. India, Indonesia, China, the Philippines, and Pakistan account for more than half of the world's cases, the WHO noted.
According to the report, 55 percent of people who developed TB were men, while 33 percent were women and 12 percent were children and young adolescents. Many of the new TB cases were driven by five major risk factors: undernutrition, HIV infection, alcohol use disorders, smoking (especially among men), and diabetes.
Tackling these issues, along with other social determinants such as poverty, requires a coordinated approach, the WHO added.
"We are confronted with a multitude of formidable challenges: funding shortfalls and catastrophic financial burden on those affected, climate change, conflict, migration and displacement, pandemics, and drug-resistant tuberculosis, a significant driver of antimicrobial resistance," Tereza Kasaeva, M.D., director of the WHO Global Tuberculosis Programme, said in the agency news release. "It is imperative that we unite across all sectors and stakeholders, to confront these pressing issues and ramp up our efforts."
Global Tuberculosis Report 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Three All-Oral Shortened Regimens Noninferior for Rifampin-Resistant TB
THURSDAY, Feb. 6, 2025 -- Three all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-susceptible, rifampin-resistant...
Health Officials Alarmed by Tuberculosis Outbreak in Kansas
TUESDAY, Jan. 28, 2025 -- Kansas health officials are tackling the largest tuberculosis (TB) outbreak in U.S. history, with 67 confirmed cases since the start of 2025. The...
Shorter Treatment Regimens Recommended for Tuberculosis
MONDAY, Jan. 13, 2025 -- In a clinical practice guideline issued by the American Thoracic Society and published in the January issue of the American Journal of Respiratory and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.